INT 0125

RADIATION THERAPY ONCOLOGY GROUP

RTOG 91-01

PHASE III DOUBLE-BLIND RANDOMIZED TRIAL OF 13-CIS RETINOIC (13-cRA) TO PREVENT SECOND PRIMARY TUMORS (SPTs) IN STAGE I NON-SMALL CELL LUNG CANCER





Study Chairmen
Medical Oncology Scott Lippman, M.D.
(713) 792-6363
FAX# (713) 796-8655
Surgical OncologyJack A. Roth, M.D.
(713) 792-6932
FAX# (713) 794-4901
Other Participants
CALGB (9293)
ECOG (91025)
MDACC & MDACCOP(ID91-025)
(Coordinating Group)
NCCTG (91-24-52)
SWOG (9221)
Activation Date (RTOG):March 17, 1993
Current Edition: October 28, 1997
Includes Revisions 1-8

THIS PROTOCOL IS COORDINATED THROUGH THE M.D. ANDERSON CANCER CENTER AND IS NOT AVAILABE ON THE WEB. TO OBTAIN A COPY OF THIS PROTOCOL PLEASE CONTACT RTOG AT (215)574-3191.